| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 1.935 | 2.664 | 552 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 5.043 | 7.865 | 5.769 | 5.201 | 5.172 |
| Total Expenses - EUR | - | - | - | - | 974 | 23.303 | 9.476 | 5.337 | 5.239 | 5.331 |
| Gross Profit/Loss - EUR | - | - | - | - | -974 | -18.260 | -1.611 | 432 | -38 | -158 |
| Net Profit/Loss - EUR | - | - | - | - | -974 | -18.280 | -1.691 | 415 | -38 | -158 |
| Employees | - | - | - | - | 0 | 3 | 6 | 4 | 0 | 0 |
Check the financial reports for the company - Naturaliss Therapy 888 Sib S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 42.041 | 39.926 | 33.751 | 28.579 | 23.253 | 17.913 |
| Current Assets | - | - | - | - | 109 | -376 | 0 | 0 | 0 | 0 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 105 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | 3 | -376 | 0 | 0 | 0 | 0 |
| Shareholders Funds | - | - | - | - | -932 | -19.194 | -20.459 | -20.108 | -20.085 | -20.130 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 935 | 20.500 | 22.015 | 21.609 | 21.544 | 21.544 |
| Income in Advance | - | - | - | - | 42.146 | 38.244 | 32.195 | 27.078 | 21.794 | 16.500 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Naturaliss Therapy 888 Sib S.r.l.